IL-1 family cytokines in cancer immunity – a matter of life and death

References

Afonina, I.S., Muller, C., Martin, S.J., and Beyaert, R. (2015). Proteolytic processing of interleukin-1 family cytokines: variations on a common theme. Immunity 42, 991–1004.10.1016/j.immuni.2015.06.003Search in Google Scholar PubMed

Akita, K., Ohtsuki, T., Nukada, Y., Tanimoto, T., Namba, M., Okura, T., Takakura-Yamamoto, R., Torigoe, K., Gu, Y., Su, MS., et al. (1997). Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells. J. Biol. Chem. 272, 26595–26603.10.1074/jbc.272.42.26595Search in Google Scholar PubMed

Bailey, S.R., Nelson, M.H., Himes, R.A., Li, Z., Mehrotra, S., and Paulos, C.M. (2014). Th17 cells in cancer: the ultimate identity crisis. Front. Immunol. 5, 276.10.3389/fimmu.2014.00276Search in Google Scholar PubMed PubMed Central

Bensen, J.T., Dawson, P.A., Mychaleckyj, J.C., and Bowden, D.W. (2001). Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14. J. Interferon. Cytokine Res. 21, 899–904.10.1089/107999001753289505Search in Google Scholar PubMed

Bergis, D., Kassis, V., and Radeke, H.H. (2016). High plasma sST2 levels in gastric cancer and their association with metastatic disease. Cancer Biomark. 16, 117–125.10.3233/CBM-150547Search in Google Scholar PubMed

Bergis, D., Kassis, V., Ranglack, A., Koeberle, V., Piiper, A., Kronenberger, B., Zeuzem, S., Waidmann, O., and Radeke, H.H. (2013). High serum levels of the interleukin-33 receptor soluble ST2 as a negative prognostic factor in hepatocellular carcinoma. Transl. Oncol. 6, 311–318.10.1593/tlo.12418Search in Google Scholar PubMed PubMed Central

Dinarello, C.A., Nold-Petry, C., Nold, M., Fujita, M., Li, S., Kim, S., and Bufler, P. (2016). Suppression of innate inflammation and immunity by interleukin-37. Eur. J. Immunol. 46, 1067–1081.10.1002/eji.201545828Search in Google Scholar PubMed PubMed Central

Dupaul-Chicoine, J., Arabzadeh, A., Dagenais, M., Douglas, T., Champagne, C., Morizot, A., Rodrigue-Gervais, I.G., Breton, V., Colpitts, S.L., Beauchemin, N., et al. (2015). The Nlrp3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting natural killer cell tumoricidal activity. Immunity 43, 751–763.10.1016/j.immuni.2015.08.013Search in Google Scholar PubMed

Eder, C. (2009). Mechanisms of interleukin-1beta release. Immunobiology 214, 543–553.10.1016/j.imbio.2008.11.007Search in Google Scholar PubMed

Fabbi, M., Carbotti, G., and Ferrini, S. (2015). Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP. J. Leukoc. Biol. 97, 665–675.10.1189/jlb.5RU0714-360RRSearch in Google Scholar PubMed

Gao, W., Kumar, S., Lotze, M.T., Hanning, C., Robbins, P.D., and Gambotto, A. (2003). Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity. J. Immunol. 170, 107–113.10.4049/jimmunol.170.1.107Search in Google Scholar PubMed

Gao, K., Li, X., Zhang, L., Bai, L., Dong, W., Gao, K., Shi, G., Xia, X., Wu, L., and Zhang, L. (2013). Transgenic expression of IL-33 activates CD8⁺ T cells and NK cells and inhibits tumor growth and metastasis in mice. Cancer Lett. 335, 463–471.10.1016/j.canlet.2013.03.002Search in Google Scholar PubMed

Gao, X., Wang, X., Yang, Q., Zhao, X., Wen, W., Li, G., Lu, J., Qin, W., Qi, Y., Xie, F., et al. (2015). Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8⁺ T and NK cells. J. Immunol. 194, 438–445.10.4049/jimmunol.1401344Search in Google Scholar PubMed PubMed Central

Garlanda, C., Dinarello, C.A., and Mantovani, A. (2013). The interleukin-1 family: back to the future. Immunity 39, 1003–1018.10.1016/j.immuni.2013.11.010Search in Google Scholar PubMed PubMed Central

Ge, G., Wang, A., Yang, J., Chen, Y., Yang, J., Li, Y., and Xue, Y. (2016). Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer. J. Exp. Clin. Cancer Res. 35, 13.10.1186/s13046-016-0293-3Search in Google Scholar PubMed PubMed Central

Ishikawa, K., Yagi-Nakanishi, S., Nakanishi, Y., Kondo, S., Tsuji, A., Endo, K., Wakisaka, N., Murono, S., and Yoshizaki, T. (2014). Expression of interleukin-33 is correlated with poor prognosis of patients with squamous cell carcinoma of the tongue. Auris Nasus Larynx 41, 552–557.10.1016/j.anl.2014.08.007Search in Google Scholar PubMed

Jiang, Y., Wang, Y., Liang, L., Gao, Y., Chen, J., Sun, Y., Cheng, Y., and Xu, Y. (2015). IL-37 mediates the antitumor activity in renal cell carcinoma. Med. Oncol. 32, 250.10.1007/s12032-015-0695-7Search in Google Scholar PubMed

Jovanovic, I.P., Pejnovic, N.N., Radosavljevic, G.D., Pantic, J.M., Milovanovic, M.Z., Arsenijevic, N.N., and Lukic, M.L. (2014). Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells. Int. J. Cancer 134, 1669–1682.10.1002/ijc.28481Search in Google Scholar PubMed

Keller, M., Ruegg, A., Werner, S., and Beer, H.D. (2008). Active caspase-1 is a regulator of unconventional protein secretion. Cell 132, 818–831.10.1016/j.cell.2007.12.040Search in Google Scholar PubMed

Khan, J.A., Brint, E.K., O’Neill, L.A., and Tong, L. (2004). Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL. J. Biol. Chem. 279, 31664–31670.10.1074/jbc.M403434200Search in Google Scholar PubMed

Komai-Koma, M., Wang, E., Kurowska-Stolarska, M., Li, D., McSharry, C., and Xu, D. (2016). Interleukin-33 promoting Th1 lymphocyte differentiation dependents on IL-12. Immunobiology 221, 412–417.10.1016/j.imbio.2015.11.013Search in Google Scholar PubMed PubMed Central

Kuraishy, A., Karin, M., and Grivennikov, S.I. (2011). Tumor promotion via injury- and death-induced inflammation. Immunity 35, 467–477.10.1016/j.immuni.2011.09.006Search in Google Scholar PubMed PubMed Central

Lauber, K., Ernst, A., Orth, M., Herrmann, M., and Belka, C. (2012). Dying cell clearance and its impact on the outcome of tumor radiotherapy. Front. Oncol. 2, 116.10.3389/fonc.2012.00116Search in Google Scholar PubMed PubMed Central

Liang, Y., Jie, Z., Hou, L., Yi, P., Wang, W., Kwota, Z., Salvato, M., de Waal Malefyt, R., Soong, L., and Sun, J. (2015). IL-33 promotes innate IFN-gamma production and modulates dendritic cell response in LCMV-induced hepatitis in mice. Eur. J. Immunol. 45, 3052–3063.10.1002/eji.201545696Search in Google Scholar PubMed PubMed Central

Lin, H., Ho, A.S., Haley-Vicente, D., Zhang, J., Bernal-Fussell, J., Pace, A.M., Hansen, D., Schweighofer, K., Mize, N.K., and Ford, J.E. (2001). Cloning and characterization of IL-1HY2, a novel interleukin-1 family member. J. Biol. Chem. 276, 20597–20602.10.1074/jbc.M010095200Search in Google Scholar PubMed

Liu, J., Shen, J.X., Hu, J.L., Huang, W.H., and Zhang, G.J. (2014a). Significance of interleukin-33 and its related cytokines in patients with breast cancers. Front. Immunol. 5, 141.10.3389/fimmu.2014.00141Search in Google Scholar PubMed PubMed Central

Liu, X., Zhu, L., Lu, X., Bian, H., Wu, X., Yang, W., and Qin, Q. (2014b). IL-33/ST2 pathway contributes to metastasis of human colorectal cancer. Biochem. Biophys Res. Commun. 453, 486–492.10.1016/j.bbrc.2014.09.106Search in Google Scholar PubMed

Lu, B., Yang, M., and Wang, Q. (2016). Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy. J. Mol. Med. (Berl) 94, 535–543.10.1007/s00109-016-1397-0Search in Google Scholar PubMed

Ma, Y., Aymeric, L., Locher, C., Mattarollo, S.R., Delahaye, N.F., Pereira, P., Boucontet, L., Apetoh, L., Ghiringhelli, F., Casares, N., et al. (2011). Contribution of IL-17-producing γδ T cells to the efficacy of anticancer chemotherapy. J. Exp. Med. 208, 491–503.10.1084/jem.20100269Search in Google Scholar PubMed PubMed Central

Ma, Z., Li, W., Yoshiya, S., Xu, Y., Hata, M., El-Darawish, Y., Markova, T., Yamanishi, K., Yamanishi, H., Tahara, H., et al. (2016). Augmentation of immune checkpoint cancer immunotherapy with IL18. Clin. Cancer Res. 22, 2969–2980.10.1158/1078-0432.CCR-15-1655Search in Google Scholar PubMed

McNamee, E.N., Masterson, J.C., Jedlicka, P., McManus, M., Grenz, A., Collins, C.B., Nold, M.F., Nold-Petry, C., Bufler, P., Dinarello, C.A., et al. (2011). Interleukin 37 expression protects mice from colitis. Proc. Natl. Acad. Sci. USA 108, 16711–16716.10.1073/pnas.1111982108Search in Google Scholar PubMed PubMed Central

Mora, J., Schlemmer, A., Wittig, I., Richter, F., Putyrski, M., Frank, A.C., Han, Y., Jung, M., Ernst, A., Weigert, A., et al. (2016). Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses. J. Mol. Cell Biol., Epub ahead of print.10.1093/jmcb/mjw006Search in Google Scholar PubMed

Netea, M.G., van de Veerdonk, F.L., van der Meer, J.W., Dinarello, C.A., and Joosten, L.A. (2015). Inflammasome-independent regulation of IL-1-family cytokines. Annu. Rev. Immunol. 33, 49–77.10.1146/annurev-immunol-032414-112306Search in Google Scholar PubMed

Pan, Q.Z., Pan, K., Zhao, J.J., Chen, J.G., Li, J.J., Lv, L., Wang, D.D., Zheng, H.X., Jiang, S.S., Zhang, X.F., et al. (2013). Decreased expression of interleukin-36alpha correlates with poor prognosis in hepatocellular carcinoma. Cancer Immunol. Immunother. 62, 1675–1685.10.1007/s00262-013-1471-1Search in Google Scholar PubMed

Pavlowsky, A., Zanchi, A., Pallotto, M., Giustetto, M., Chelly, J., Sala, C., and Billuart, P. (2010). Neuronal JNK pathway activation by IL-1 is mediated through IL1RAPL1, a protein required for development of cognitive functions. Commun. Integr. Biol. 3, 245–247.10.4161/cib.3.3.11414Search in Google Scholar PubMed PubMed Central

Tong, X., Barbour, M., Hou, K., Gao, C., Cao, S., Zheng, J., Zhao, Y., Mu, R., and Jiang, H.R. (2016). Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways. Mol. Oncol. 10, 113–125.10.1016/j.molonc.2015.06.004Search in Google Scholar PubMed PubMed Central

Trinchieri, G. (2012). Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu. Rev. Immunol. 30, 677–706.10.1146/annurev-immunol-020711-075008Search in Google Scholar PubMed

Tsuda, H., Komine, M., Karakawa, M., Etoh, T., Tominaga, S., and Ohtsuki, M. (2012). Novel splice variants of IL-33: differential expression in normal and transformed cells. J. Invest. Dermatol. 132, 2661–2664.10.1038/jid.2012.180Search in Google Scholar PubMed

van de Veerdonk, F.L., Stoeckman, A.K., Wu, G., Boeckermann, A.N., Azam, T., Netea, M.G., Joosten, L.A., van der Meer, J.W., Hao, R., Kalabokis, V., et al. (2012). IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc. Natl. Acad. Sci. USA 109, 3001–3005.10.1073/pnas.1121534109Search in Google Scholar PubMed PubMed Central

Villarreal, D.O. and Weiner, D.B. (2014). Interleukin 33: a switch-hitting cytokine. Curr. Opin. Immunol. 28, 102–106.10.1016/j.coi.2014.03.004Search in Google Scholar PubMed PubMed Central

Voronov, E., Dotan, S., Krelin, Y., Song, X., Elkabets, M., Carmi, Y., Rider, P., Idan, C., Romzova, M., Kaplanov, I., et al. (2013). Unique versus redundant functions of IL-1α and IL-1β in the tumor microenvironment. Front. Immunol. 4, 177.10.3389/fimmu.2013.00177Search in Google Scholar PubMed PubMed Central

Wang, Z.S., Cong, Z.J., Luo, Y., Mu, Y.F., Qin, S.L., Zhong, M., and Chen, J.J. (2014). Decreased expression of interleukin-36α predicts poor prognosis in colorectal cancer patients. Int. J. Clin. Exp. Pathol. 7, 8077–8081.Search in Google Scholar

Wang, S., An, W., Yao, Y., Chen, R., Zheng, X., Yang, W., Zhao, Y., Hu, X., Jiang, E., Bie, Y., et al. (2015a). Interleukin 37 expression inhibits STAT3 to suppress the proliferation and invasion of human cervical cancer cells. J. Cancer 6, 962–969.10.7150/jca.12266Search in Google Scholar PubMed PubMed Central

Wang, X., Zhao, X., Feng, C., Weinstein, A., Xia, R., Wen, W., Lv, Q., Zuo, S., Tang, P., Yang, X., et al. (2015b). IL-36γ transforms the tumor microenvironment and promotes type 1 lymphocyte-mediated antitumor immune responses. Cancer Cell 28, 296–306.10.1016/j.ccell.2015.07.014Search in Google Scholar PubMed PubMed Central

Willems, J.J., Arnold, B.P., and Gregory, C.D. (2014). Sinister self-sacrifice: the contribution of apoptosis to malignancy. Front. Immunol. 5, 299.10.3389/fimmu.2014.00299Search in Google Scholar PubMed PubMed Central

Xu, D., Chan, W.L., Leung, B.P., Huang, F., Wheeler, R., Piedrafita, D., Robinson, J.H., and Liew, F.Y. (1998). Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 187, 787–794.10.1084/jem.187.5.787Search in Google Scholar PubMed PubMed Central

Yang, Q., Li, G., Zhu, Y., Liu, L., Chen, E., Turnquist, H., Zhang, X., Finn, O.J., Chen, X., and Lu, B. (2011). IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8⁺ T cells. Eur. J. Immunol. 41, 3351–3360.10.1002/eji.201141629Search in Google Scholar PubMed PubMed Central

Yang, Z.P., Ling, D.Y., Xie, Y.H., Wu, W.X., Li, J.R., Jiang, J., Zheng, J.L., Fan, Y.H., and Zhang, Y. (2015). The association of serum IL-33 and sST2 with breast cancer. Dis. Markers 2015, 516895.10.1155/2015/516895Search in Google Scholar PubMed PubMed Central

Yu, X.X., Hu, Z., Shen, X., Dong, L.Y., Zhou, W.Z., and Hu, W.H. (2015). IL-33 promotes gastric cancer cell invasion and migration via ST2-ERK1/2 pathway. Dig. Dis. Sci. 60, 1265–1272.10.1007/s10620-014-3463-1Search in Google Scholar PubMed

Zhao, J.J., Pan, Q.Z., Pan, K., Weng, D.S., Wang, Q.J., Li, J.J., Lv, L., Wang, D.D., Zheng, H.X., Jiang, S.S., et al. (2014). Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57⁺ NK cells. Sci. Rep. 4, 5177.10.1038/srep05177Search in Google Scholar PubMed PubMed Central

Zitvogel, L., Kepp, O., and Kroemer, G. (2011). Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat. Rev. Clin. Oncol. 8, 151–160.10.1038/nrclinonc.2010.223Search in Google Scholar PubMed

Zitvogel, L., Kepp, O., Galluzzi, L., and Kroemer, G. (2012). Inflammasomes in carcinogenesis and anticancer immune responses. Nat. Immunol. 13, 343–351.10.1038/ni.2224Search in Google Scholar PubMed